Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I M E Desar

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The Netherlands Journal of Medicine|January 25, 2014
Fatal microscopic pulmonary tumour embolisms in patients with breast cancer: necessary knowledge for future medical practiceM Vlenterie, I M E Desar, C M L van Herpen, et al.
Critical Reviews in Oncology/Hematology|February 21, 2018
Systemic treatment in adult uterine sarcomasI M E Desar, P B Ottevanger, C Benson, et al.
Acta Oncologica (Stockholm, Sweden)|July 27, 2019
Predictive factors for toxicity and survival of second-line sunitinib in advanced gastrointestinal stromal tumours (GIST)D Den Hollander, W T A Van der Graaf, I M E Desar, et al.
The Netherlands Journal of Medicine|December 7, 2007
Reversible hypogammaglobulinaemiaI M E Desar, C M R Weemaes, M van Deuren, et al.
Critical Reviews in Oncology/Hematology|May 17, 2019
Targeting angiosarcomas of the soft tissues: A challenging effort in a heterogeneous and rare diseaseM E Weidema, Y M H Versleijen-Jonkers, U E Flucke, et al.
The Netherlands Journal of Medicine|April 19, 2018
Drug-drug interactions with aprepitant in antiemetic prophylaxis for chemotherapyR Schoffelen, A G Lankheet, C M L van Herpen, et al.
British Journal of Cancer|November 4, 2010
A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancerI M E Desar, J N H Timmer-Bonte, D M Burger, et al.
The Netherlands Journal of Medicine|August 4, 2012
Kidney injury during VEGF inhibitor therapyE S G den Deurwaarder, I M E Desar, E J Steenbergen, et al.
Clinical and Experimental Immunology|May 15, 2009
Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemiaI M E Desar, M van Deuren, T Sprong, et al.
Immunologic Research|January 19, 2022
Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroupsT Tomassen, M E Weidema, M H S Hillebrandt-Roeffen, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The Netherlands Journal of Medicine|January 25, 2014
Fatal microscopic pulmonary tumour embolisms in patients with breast cancer: necessary knowledge for future medical practiceM Vlenterie, I M E Desar, C M L van Herpen, et al.
Critical Reviews in Oncology/Hematology|February 21, 2018
Systemic treatment in adult uterine sarcomasI M E Desar, P B Ottevanger, C Benson, et al.
Acta Oncologica (Stockholm, Sweden)|July 27, 2019
Predictive factors for toxicity and survival of second-line sunitinib in advanced gastrointestinal stromal tumours (GIST)D Den Hollander, W T A Van der Graaf, I M E Desar, et al.
The Netherlands Journal of Medicine|December 7, 2007
Reversible hypogammaglobulinaemiaI M E Desar, C M R Weemaes, M van Deuren, et al.
Critical Reviews in Oncology/Hematology|May 17, 2019
Targeting angiosarcomas of the soft tissues: A challenging effort in a heterogeneous and rare diseaseM E Weidema, Y M H Versleijen-Jonkers, U E Flucke, et al.
The Netherlands Journal of Medicine|April 19, 2018
Drug-drug interactions with aprepitant in antiemetic prophylaxis for chemotherapyR Schoffelen, A G Lankheet, C M L van Herpen, et al.
British Journal of Cancer|November 4, 2010
A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancerI M E Desar, J N H Timmer-Bonte, D M Burger, et al.
The Netherlands Journal of Medicine|August 4, 2012
Kidney injury during VEGF inhibitor therapyE S G den Deurwaarder, I M E Desar, E J Steenbergen, et al.
Clinical and Experimental Immunology|May 15, 2009
Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemiaI M E Desar, M van Deuren, T Sprong, et al.
Immunologic Research|January 19, 2022
Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroupsT Tomassen, M E Weidema, M H S Hillebrandt-Roeffen, et al.
Pageof 3